IgG(4)-mediated allergic reaction to glargine insulin.
Madero
M F
MF
Fundación Jiménez Díaz, Servicio de Alergia, Av. Reyes Católicos 2, 28040 Madrid, Spain. jsastre@fjd.es
Sastre
J
J
Carnés
J
J
Quirce
S
S
Herrera-Pombo
J L
JL
D000328:Adult; D003876:Dermatitis, Atopic / Q000097:blood* / Q000209:etiology; D048909:Diabetes Complications / Q000097:blood* / Q000209:etiology; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000188:drug therapy; D004342:Drug Hypersensitivity / Q000097:blood* / Q000209:etiology; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007074:Immunoglobulin G / Q000097:blood*; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D007330:Insulin Antibodies / Q000097:blood*; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting
D007004:Hypoglycemic Agents; D007074:Immunoglobulin G; D007328:Insulin; D007330:Insulin Antibodies; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine